David Newman, GlaxoSmithKline

Published on: 

Pharmaceutical Executive

Pharmaceutical Executive, Pharmaceutical Executive-06-01-2008, Volume 0, Issue 0


David Newman

Senior Product Director, Tykerb, GlaxoSmithKline

NOTED FOR: Launch of oncology treatment Tykerb


EXCEEDED RESULTS: Treated 5,500 patients

On what motivates him to succeed:

We think we have it tough. But that's nothing compared to fighting breast cancer. These women help us put our work in perspective, and give us a sense of mission to not necessarily sell Tykerb, but instead make sure every patient gets its benefit of efficacy.

David Newman

In a therapeutic area like oncology, you have a chance to make a real difference. That focus is what keeps me motivated day in and day out.